Feasibility of the IC-Flow Device for Fluorescent Perfusion Evaluation During Feasibility of the IC-Flow Device

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Skin Flap NecrosisPerfusion; Complications
Interventions
PROCEDURE

Perfusion evaluation with indocyanine green

"1\. At least 10 minutes before surgery, will receive a weight-scaled dose of indocyanine green by IV and the time of administration and any adverse reactions will be recorded. The Surgeon/researcher will visualize and record the images given by the KARL STORZ VITOM II ICG System and the IC-Flow camera.~3\. The surgery will proceed as planned pre-operatively. The surgeon will conduct the surgery under white light and will categorize initial visualization of the organs."

Trial Locations (1)

33331

Cleveland Clinic Florida, Weston

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT03860493 - Feasibility of the IC-Flow Device for Fluorescent Perfusion Evaluation During Feasibility of the IC-Flow Device | Biotech Hunter | Biotech Hunter